-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
![CNAPS NHL featured](https://volition.com/wp-content/uploads/2024/03/CNAPS-NHL-featured.jpg)
Identification of an epigenetic profile of circulating nucleosomes in Non-Hodgkin Lymphoma as potential biomarkers of the disease
- Share
- Tweet
- Share on Facebook
- Share
![Screenshot 2024-02-29 160250](https://volition.com/wp-content/uploads/2024/02/Screenshot-2024-02-29-160250.png)
![Screenshot 2024-02-29 160250](https://volition.com/wp-content/uploads/2024/02/Screenshot-2024-02-29-160250.png)
Poster titled: “Identification of an epigenetic profile of circulating nucleosomes in Non-Hodgkin Lymphoma as potential biomarkers of the disease.”
Presented at CNAPS 2024
Donis et al
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields